GERN Q2 2025 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M+5459.6% YoY

Gross Profit

$48M97.6% margin

Operating Income

-$12M-25.4% margin

Net Income

-$16M-33.4% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+23.8%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$28M

Stock-Based Comp.

-$7M

Balance Sheet

Total Assets

$555M

Total Liabilities

$296M

Stockholders' Equity

$260M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$882,000	+5459.6%
Gross Profit	$48M	$865,000	+5431.3%
Operating Income	-$12M	-$69M	+82.0%
Net Income	-$16M	-$67M	+75.7%

Revenue Segments

Revenues Before Adjustments

$58M54%

Product

$49M46%